Structure based drug design
From DISI
Revision as of 21:15, 20 September 2007; JohnIrwin (Talk | contribs)
(diff) ←Older revision | Current revision | Newer revision→ (diff)
(diff) ←Older revision | Current revision | Newer revision→ (diff)
Structure based drug design includes virtual screening, but also more low-throughput methods such as having a medicinal chemist just look at a model and propose new compounds to make and test.

